trending Market Intelligence /marketintelligence/en/news-insights/trending/9yJnqYrm2iiHmdgRP1fGHg2 content esgSubNav
In This List

Avita Medical appoints CEO

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Avita Medical appoints CEO

Avita Medical Ltd. appointed Michael Perry as CEO, effective June 2.

Previously, Perry has served as senior vice president and chief scientific officer of global business development and licensing for Novartis AG.